{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T23:07:21Z","timestamp":1769209641732,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"crossref","award":["111-2-07"],"award-info":[{"award-number":["111-2-07"]}],"id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["ZL2014SK0035"],"award-info":[{"award-number":["ZL2014SK0035"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.antiviral.2016.01.011","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T16:57:58Z","timestamp":1453395478000},"page":"68-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Antiviral activity of SA-2 against influenza A virus in\u00a0vitro\/vivo and its inhibition of RNA polymerase"],"prefix":"10.1016","volume":"127","author":[{"given":"Jie","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dechuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Dou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5910-4259","authenticated-orcid":false,"given":"Changlin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.01.011_bib1","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1021\/jm980707k","article-title":"Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent","volume":"42","author":"Atigadda","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2016.01.011_bib2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1517\/17460441.2012.674510","article-title":"Screening methods for influenza antiviral drug discovery","volume":"7","author":"Atkins","year":"2012","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.antiviral.2016.01.011_bib3","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1016\/j.bmcl.2012.05.035","article-title":"SAR analysis of a series of acylthiourea derivatives possessing broad-spectrum antiviral activity","volume":"22","author":"Burgeson","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2016.01.011_bib4","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1128\/AAC.04623-14","article-title":"Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit","volume":"59","author":"Byrn","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.01.011_bib5","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.antiviral.2011.07.008","article-title":"Synergistic activity of baicalein with ribavirin against influenza A (H1N1) virus infections in cell culture and in mice","volume":"91","author":"Chen","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.01.011_bib6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4269\/ajtmh.1958.7.561","article-title":"Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses","volume":"7","author":"Clarke","year":"1958","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2016.01.011_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.antiviral.2011.03.182","article-title":"In\u00a0vitro antiviral activity of arbidol against Chikungunya virus and characteristics of a selected resistant mutant","volume":"90","author":"Delogu","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.01.011_bib8","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1007\/s00705-014-2192-2","article-title":"Antiviral activity of baicalin against influenza A (H1N1\/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase","volume":"159","author":"Ding","year":"2014","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2016.01.011_bib9","first-page":"814598","article-title":"Gender differences of B cell signature in healthy subjects underlie disparities in incidence and course of SLE related to estrogen","volume":"2014","author":"Fan","year":"2014","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.antiviral.2016.01.011_bib10","first-page":"1","article-title":"Prevention and control of influenza: recommendations of the advisory committee on immunization practices (ACIP)","volume":"57","author":"Fiore","year":"2008","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.antiviral.2016.01.011_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.antiviral.2009.02.198","article-title":"T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA viral infections","volume":"82","author":"Furuta","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.01.011_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coviro.2014.04.009","article-title":"The epidemiology and spread of drug resistant human influenza viruses","volume":"8","author":"Hurt","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2016.01.011_bib14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3858\/emm.2010.42.2.013","article-title":"Reverse genetic platform for inactivated and live-attenuated influenza vaccine","volume":"42","author":"Jung","year":"2010","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.antiviral.2016.01.011_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1126\/science.1232552","article-title":"Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity","volume":"340","author":"Kim","year":"2013","journal-title":"Science"},{"issue":"463","key":"10.1016\/j.antiviral.2016.01.011_bib16","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nature08699","article-title":"Human host factors required for influenza virus replication","volume":"2010","author":"Konig","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.01.011_bib17","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.antiviral.2012.12.016","article-title":"Influenza antiviral resistance in the Asia-Pacific region during 2011","volume":"97","author":"Leang","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.01.011_bib18","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJMoa1304617","article-title":"Epidemiology of human infections with avian influenza A (H7N9) virus in China","volume":"370","author":"Li","year":"2014","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.antiviral.2016.01.011_bib19","doi-asserted-by":"crossref","first-page":"8493","DOI":"10.1021\/jm3009844","article-title":"Enhanced anti-influenza agents conjugated with anti-inflammatory activity","volume":"55","author":"Liu","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2016.01.011_bib20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2 (\u2013 Delta Delta C (T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.antiviral.2016.01.011_bib21","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMra050740","article-title":"Neuraminidase inhibitors for influenza","volume":"353","author":"Moscona","year":"2005","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.antiviral.2016.01.011_bib22","first-page":"493","article-title":"A\u00a0simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.antiviral.2016.01.011_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbrc.2014.05.058","article-title":"Identification of a novel multiple kinase inhibitor with potent antiviral activity against influenza virus by reducing viral polymerase activity","volume":"450","author":"Sasaki","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2016.01.011_bib24","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.2165\/00003495-200464180-00003","article-title":"Antiviral therapy for influenza: a clinical and economic comparative review","volume":"64","author":"Schmidt","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.antiviral.2016.01.011_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1423-0127-17-13","article-title":"Pyarzole compound BPR1P0034 with potent and selective anti-influenza virus activity","volume":"17","author":"Shih","year":"2010","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.antiviral.2016.01.011_bib26","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bmcl.2005.09.033","article-title":"A\u00a0novel class of potent influenza virus inhibitors: polysubstituted acylthiourea and its fused heterocycle derivatives","volume":"16","author":"Sun","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2016.01.011_bib27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/ng1072","article-title":"Heterozygosity with respect to Zfp148 causes complete loss of fetal germ cells during mouse embryogenesis","volume":"33","author":"Takeuchi","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.antiviral.2016.01.011_bib28","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1093\/jac\/dku127","article-title":"A\u00a0zanamivir dimer with prophylactic and enhanced therapeutic activity against influenza viruses","volume":"69","author":"Tarbet","year":"2014","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2016.01.011_bib29","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2334-11-134","article-title":"Systematic review of influenza resistance to the neuraminidase inhibitors","volume":"11","author":"Thorlund","year":"2011","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.01.011_bib30","unstructured":"Wang, D., Yu, J., Zhou, Y., Zhou, C., Ding, Y., Zhao, J., Dou, J., 2015a Mar. 25. Synthesis and Anti-influenza Application for a Series of Benzoic Acid Thiourea Compounds. Chinese patent CN104447481A."},{"key":"10.1016\/j.antiviral.2016.01.011_bib31","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1128\/CVI.00091-15","article-title":"Protective efficacy of the conserved NP, PB1, and M1 proteins as immunogens in DNA- and vaccinia virus-based universal influenza A virus vaccines in mice","volume":"22","author":"Wang","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.antiviral.2016.01.011_bib32","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.chom.2014.11.002","article-title":"Influenza virus-host interactome screen as a platform for antiviral drug development","volume":"16","author":"Watanabe","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2016.01.011_bib33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.chom.2010.05.008","article-title":"Cellular networks involved in the influenza virus life cycle","volume":"7","author":"Watanabe","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2016.01.011_bib34","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/infdis\/jiu353","article-title":"The R292K mutation that confers resistance to neuraminidase inhibitors leads to competitive fitness loss of A\/Shanghai\/1\/2013 (H7N9) influenza virus in ferrets","volume":"210","author":"Yen","year":"2014","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.01.011_bib35","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.antiviral.2011.10.014","article-title":"Identification of novel virus inhibitors by influenza A virus specific reporter cell based screening","volume":"93","author":"Zhang","year":"2012","journal-title":"Antivir. Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216300134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216300134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T10:22:02Z","timestamp":1589624522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216300134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":34,"alternative-id":["S0166354216300134"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.01.011","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral activity of SA-2 against influenza A virus in\u00a0vitro\/vivo and its inhibition of RNA polymerase","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}